ANUH PHARMA
|
ANUH PHARMA Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹13 Cr | ₹13 Cr |
Equity - Authorised | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Equity - Issued | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹13 Cr | ₹13 Cr |
Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹13 Cr | ₹13 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹216 Cr | ₹189 Cr | ₹166 Cr | ₹150 Cr | ₹152 Cr |
Securities Premium | - | - | - | - | - |
Capital Reserves | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.08 Cr |
Profit & Loss Account Balance | ₹114 Cr | ₹93 Cr | ₹76 Cr | ₹54 Cr | ₹56 Cr |
General Reserves | ₹102 Cr | ₹95 Cr | ₹89 Cr | ₹96 Cr | ₹96 Cr |
Other Reserves | ₹0.09 Cr | ₹0.06 Cr | ₹-0.03 Cr | ₹-0.03 Cr | ₹0.06 Cr |
Reserve excluding Revaluation Reserve | ₹216 Cr | ₹189 Cr | ₹166 Cr | ₹150 Cr | ₹152 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹241 Cr | ₹214 Cr | ₹191 Cr | ₹162 Cr | ₹165 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.77 Cr | ₹0.05 Cr | ₹1.01 Cr | ₹0.21 Cr | ₹-0.91 Cr |
Deferred Tax Assets | ₹1.04 Cr | ₹0.84 Cr | ₹1.01 Cr | ₹1.18 Cr | ₹0.91 Cr |
Deferred Tax Liability | ₹0.27 Cr | ₹0.89 Cr | ₹2.02 Cr | ₹1.39 Cr | - |
Other Long Term Liabilities | ₹0.84 Cr | ₹0.91 Cr | - | ₹0.08 Cr | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.58 Cr | ₹1.54 Cr | ₹1.51 Cr | ₹1.17 Cr | ₹0.87 Cr |
Total Non-Current Liabilities | ₹1.66 Cr | ₹2.50 Cr | ₹2.53 Cr | ₹1.46 Cr | ₹-0.04 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹153 Cr | ₹122 Cr | ₹120 Cr | ₹105 Cr | ₹59 Cr |
Sundry Creditors | ₹153 Cr | ₹122 Cr | ₹120 Cr | ₹105 Cr | ₹59 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹8.50 Cr | ₹6.16 Cr | ₹5.76 Cr | ₹13 Cr | ₹11 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹3.13 Cr | ₹1.42 Cr | ₹0.66 Cr | ₹4.39 Cr | ₹1.45 Cr |
Interest Accrued But Not Due | - | ₹0.00 Cr | - | ₹0.16 Cr | ₹0.03 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹5.38 Cr | ₹4.75 Cr | ₹5.10 Cr | ₹8.76 Cr | ₹9.71 Cr |
Short Term Borrowings | - | ₹3.11 Cr | ₹14 Cr | ₹45 Cr | ₹4.39 Cr |
Secured ST Loans repayable on Demands | - | ₹3.11 Cr | ₹14 Cr | ₹45 Cr | ₹4.39 Cr |
Working Capital Loans- Sec | - | - | ₹14 Cr | ₹45 Cr | ₹4.39 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | ₹-14 Cr | ₹-45 Cr | ₹-4.39 Cr |
Short Term Provisions | ₹0.07 Cr | ₹0.06 Cr | ₹0.10 Cr | ₹0.20 Cr | ₹0.31 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | - | - | - | ₹0.13 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.07 Cr | ₹0.06 Cr | ₹0.10 Cr | ₹0.20 Cr | ₹0.19 Cr |
Total Current Liabilities | ₹161 Cr | ₹131 Cr | ₹139 Cr | ₹163 Cr | ₹75 Cr |
Total Liabilities | ₹404 Cr | ₹347 Cr | ₹333 Cr | ₹326 Cr | ₹239 Cr |
ASSETS | |||||
Gross Block | ₹100 Cr | ₹100 Cr | ₹98 Cr | ₹96 Cr | ₹27 Cr |
Less: Accumulated Depreciation | ₹47 Cr | ₹38 Cr | ₹27 Cr | ₹12 Cr | ₹5.34 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹53 Cr | ₹61 Cr | ₹71 Cr | ₹84 Cr | ₹21 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | ₹0.10 Cr | - | - | ₹34 Cr |
Non Current Investments | ₹40 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr | ₹30 Cr |
Long Term Investment | ₹40 Cr | ₹21 Cr | ₹20 Cr | ₹14 Cr | ₹30 Cr |
Quoted | ₹1.81 Cr | ₹1.81 Cr | ₹1.81 Cr | ₹1.81 Cr | ₹1.81 Cr |
Unquoted | ₹38 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr | ₹28 Cr |
Long Term Loans & Advances | ₹4.11 Cr | ₹2.20 Cr | ₹2.62 Cr | ₹2.68 Cr | ₹2.13 Cr |
Other Non Current Assets | - | ₹3.55 Cr | ₹0.50 Cr | ₹3.00 Cr | - |
Total Non-Current Assets | ₹97 Cr | ₹88 Cr | ₹95 Cr | ₹103 Cr | ₹87 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹51 Cr | ₹21 Cr | ₹11 Cr | ₹66 Cr | ₹8.62 Cr |
Quoted | - | - | ₹4.95 Cr | - | - |
Unquoted | ₹51 Cr | ₹21 Cr | ₹6.07 Cr | ₹66 Cr | ₹8.62 Cr |
Inventories | ₹73 Cr | ₹80 Cr | ₹81 Cr | ₹61 Cr | ₹43 Cr |
Raw Materials | ₹35 Cr | ₹46 Cr | ₹53 Cr | ₹31 Cr | ₹26 Cr |
Work-in Progress | ₹9.81 Cr | ₹7.97 Cr | ₹3.15 Cr | ₹3.78 Cr | ₹4.62 Cr |
Finished Goods | ₹9.71 Cr | ₹25 Cr | ₹25 Cr | ₹27 Cr | ₹12 Cr |
Packing Materials | ₹0.19 Cr | ₹0.14 Cr | ₹0.09 Cr | ₹0.07 Cr | ₹0.09 Cr |
Stores Ā and Spare | - | - | - | - | - |
Other Inventory | ₹18 Cr | ₹0.29 Cr | ₹0.24 Cr | ₹0.15 Cr | ₹0.04 Cr |
Sundry Debtors | ₹171 Cr | ₹136 Cr | ₹107 Cr | ₹81 Cr | ₹75 Cr |
Debtors more than Six months | ₹0.37 Cr | ₹0.21 Cr | ₹0.40 Cr | - | - |
Debtors Others | ₹171 Cr | ₹136 Cr | ₹107 Cr | ₹81 Cr | ₹75 Cr |
Cash and Bank | ₹6.65 Cr | ₹16 Cr | ₹20 Cr | ₹2.52 Cr | ₹11 Cr |
Cash in hand | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Balances at Bank | ₹6.64 Cr | ₹16 Cr | ₹20 Cr | ₹2.50 Cr | ₹11 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.67 Cr | ₹1.00 Cr | ₹17 Cr | ₹7.32 Cr | ₹11 Cr |
Interest accrued on Investments | ₹0.09 Cr | ₹0.18 Cr | ₹0.10 Cr | ₹0.08 Cr | ₹0.08 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | ₹0.23 Cr | ₹0.02 Cr | ₹0.05 Cr | ₹0.03 Cr |
Prepaid Expenses | ₹0.57 Cr | ₹0.48 Cr | ₹0.44 Cr | ₹0.27 Cr | ₹0.23 Cr |
Other current_assets | ₹0.02 Cr | ₹0.11 Cr | ₹16 Cr | ₹6.92 Cr | ₹11 Cr |
Short Term Loans and Advances | ₹5.27 Cr | ₹4.63 Cr | ₹1.53 Cr | ₹4.73 Cr | ₹3.43 Cr |
Advances recoverable in cash or in kind | ₹0.99 Cr | ₹0.08 Cr | ₹0.14 Cr | ₹0.34 Cr | ₹0.39 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹4.29 Cr | ₹4.55 Cr | ₹1.40 Cr | ₹4.39 Cr | ₹3.05 Cr |
Total Current Assets | ₹308 Cr | ₹259 Cr | ₹238 Cr | ₹223 Cr | ₹152 Cr |
Net Current Assets (Including Current Investments) | ₹146 Cr | ₹128 Cr | ₹98 Cr | ₹60 Cr | ₹77 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹404 Cr | ₹347 Cr | ₹333 Cr | ₹326 Cr | ₹239 Cr |
Contingent Liabilities | ₹29 Cr | ₹33 Cr | ₹23 Cr | ₹33 Cr | ₹15 Cr |
Total Debt | - | ₹3.11 Cr | ₹14 Cr | ₹45 Cr | ₹4.39 Cr |
Book Value | 48.14 | 42.66 | 38.04 | 64.74 | 65.69 |
Adjusted Book Value | 48.14 | 42.66 | 38.04 | 32.37 | 32.85 |
Compare Balance Sheet of peers of ANUH PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ANUH PHARMA | ₹1,280.3 Cr | 6.1% | 5.7% | 186.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
ANUH PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ANUH PHARMA | 6.1% |
5.7% |
186.2% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses